InsidersTradesSigma
Follow the Cutia Therapeutics - B stock price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Market capitalisation: €710.4m. The latest transaction was reported on 3 July 2026 (Other). Among the most active insiders: Zhang Lele. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Cutia Therapeutics - B is a company focused on developing innovative treatments for chronic diseases. It specializes in research and the advancement of therapeutic solutions.